Claritin and Angiomyolipoma - a phase IV clinical study of FDA data

Summary:

Angiomyolipoma is reported as a side effect among people who take Claritin (loratadine), especially for people who are female, 50-59 old, also take Remeron, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Angiomyolipoma when taking Claritin. It is created by eHealthMe based on reports of 74,516 people who have side effects when taking Claritin from the FDA, and is updated regularly.

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,316 Claritin users. Check the latest studies of Claritin.

What is Angiomyolipoma?

Angiomyolipoma (most common benign tumour of the kidney) is found to be associated with 103 drugs and 153 conditions by eHealthMe. Check the latest studies of Angiomyolipoma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

74,516 people reported to have side effects when taking Claritin.
Among them, 15 people (0.02%) have Angiomyolipoma.

Among these 15 people:

What is the gender of people who have Angiomyolipoma when taking Claritin? *

female: 86.67 %
male: 13.33 %

What is the age of people who have Angiomyolipoma when taking Claritin? *

What are other drugs people take besides Claritin? *

What are other side effects people have besides Angiomyolipoma? *

Pain: 15 people, 100.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 14 people, 93.33%
Osteomyelitis (infection of bone): 14 people, 93.33%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 14 people, 93.33%
Migraine (headache): 14 people, 93.33%
Metastases To Bone (cancer spreads to bone): 14 people, 93.33%
Intervertebral Disc Degeneration (spinal disc degeneration): 14 people, 93.33%
Injury: 14 people, 93.33%
Infection: 14 people, 93.33%
High Blood Cholesterol: 14 people, 93.33%

What are the existing conditions these people have? *

Breast Cancer Metastatic: 14 people, 93.33%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 6.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Claritin and have Angiomyolipoma?

- Check whether Angiomyolipoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Claritin:

Claritin (77,316 reports)

Angiomyolipoma treatments and more:

Angiomyolipoma (1,753 reports)

Browse all side effects of Claritin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Angiomyolipoma:

Angiomyolipoma (103 drugs)

Browse all the conditions that are associated with Angiomyolipoma:

Angiomyolipoma (153 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on loratadine (the active ingredients of Claritin) and Claritin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.